Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Viskoper

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Harefuah|August 26, 2000
[Multicenter community-based trial of amlodipine in hypertension in Israel]C Yosefy, J R Viskoper, Y Leshem, et al.
BMJ (Clinical Research Ed.)|December 9, 2000
Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) studyC E Mogensen, S Neldam, I Tikkanen, et al.
Journal of Human Hypertension|December 1, 1999
Prior antihypertensive treatment and admission blood pressure correlated with clinical outcome and early morning presentation in hypertensive ischaemic stroke patientsC Yosefy, L Linov, J R Viskoper, et al.
Blood Pressure|November 5, 2003
Risk factor profile and achievement of treatment goals among hypertensive patients from the Israeli Blood Pressure Control (IBPC) program--initial cost utility analysisC Yosefy, G M Ginsberg, D Dicker, et al.
Preventive Medicine|November 26, 2003
The Ashkelon Hypertension Detection and Control Program (AHDC Program): a community approach to reducing cardiovascular mortalityC Yosefy, D Dicker, J R Viskoper, et al.
Journal of Human Hypertension|December 1, 1993
Comprehensive individualised nonpharmacological treatment programme for hypertension in physician-nurse clinics: two year follow-upZ Fuchs, J R Viskoper, I Drexler, et al.
Journal of Human Hypertension|September 1, 1996
Repeated fasting and refeeding with 20:5, n-3 eicosapentaenoic acid (EPA): a novel approach for rapid fatty acid exchange and its effect on blood pressure, plasma lipids and hemostasisC Yosefy, J R Viskoper, D Varon, et al.
British Journal of Biomedical Science|October 17, 2003
Impaired nitric oxide production, brachial artery reactivity and fish oil in offspring of ischaemic heart disease patientsC Yosefy, V Khalamizer, J R Viskoper, et al.
British Journal of Clinical Pharmacology|February 1, 1995
Reproducibility of angiotensin converting enzyme inhibitor induced cough: a double-blind randomised studyV Charlon, S Dollow, J Fidel, et al.
Journal of Human Hypertension|December 1, 1993
Partial cost-benefit analysis of two different modes of nonpharmacological control of hypertension in the communityG M Ginsberg, J R Viskoper, Z Fuchs, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Harefuah|August 26, 2000
[Multicenter community-based trial of amlodipine in hypertension in Israel]C Yosefy, J R Viskoper, Y Leshem, et al.
BMJ (Clinical Research Ed.)|December 9, 2000
Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) studyC E Mogensen, S Neldam, I Tikkanen, et al.
Journal of Human Hypertension|December 1, 1999
Prior antihypertensive treatment and admission blood pressure correlated with clinical outcome and early morning presentation in hypertensive ischaemic stroke patientsC Yosefy, L Linov, J R Viskoper, et al.
Blood Pressure|November 5, 2003
Risk factor profile and achievement of treatment goals among hypertensive patients from the Israeli Blood Pressure Control (IBPC) program--initial cost utility analysisC Yosefy, G M Ginsberg, D Dicker, et al.
Preventive Medicine|November 26, 2003
The Ashkelon Hypertension Detection and Control Program (AHDC Program): a community approach to reducing cardiovascular mortalityC Yosefy, D Dicker, J R Viskoper, et al.
Journal of Human Hypertension|December 1, 1993
Comprehensive individualised nonpharmacological treatment programme for hypertension in physician-nurse clinics: two year follow-upZ Fuchs, J R Viskoper, I Drexler, et al.
Journal of Human Hypertension|September 1, 1996
Repeated fasting and refeeding with 20:5, n-3 eicosapentaenoic acid (EPA): a novel approach for rapid fatty acid exchange and its effect on blood pressure, plasma lipids and hemostasisC Yosefy, J R Viskoper, D Varon, et al.
British Journal of Biomedical Science|October 17, 2003
Impaired nitric oxide production, brachial artery reactivity and fish oil in offspring of ischaemic heart disease patientsC Yosefy, V Khalamizer, J R Viskoper, et al.
British Journal of Clinical Pharmacology|February 1, 1995
Reproducibility of angiotensin converting enzyme inhibitor induced cough: a double-blind randomised studyV Charlon, S Dollow, J Fidel, et al.
Journal of Human Hypertension|December 1, 1993
Partial cost-benefit analysis of two different modes of nonpharmacological control of hypertension in the communityG M Ginsberg, J R Viskoper, Z Fuchs, et al.
Pageof 4